AI assistant
EXAGEN INC. — Director's Dealing 2022
Oct 18, 2022
33644_dirs_2022-10-18_cd0414d9-3cca-4dec-8b7d-c6e0a67225d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2022-10-16
Reporting Person: ABALLI JOHN (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-10-16 | Restricted Stock Units | A | 350000 | — | Acquired | 350000 | Direct |
Footnotes
F1: The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of October 16, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control.